Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - valaciclovir hydrochloride monohydrate, quantity: 305.85 mg - tablet, film coated - excipient ingredients: povidone; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; hyprolose; macrogol 400 - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. for the treatment of opthalmic zoster. for the treatment of recurrent herpes labialis (cold sores). for the treatment of clinical episodes of genital herpes simplex infections. reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with valaciclovir actavis, it is recommended that patients use safer sex practices (see precautions). prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

aurobindo pharma australia pty ltd - valaciclovir hydrochloride; valaciclovir -

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - valaciclovir hydrochloride, quantity: 1112 mg (equivalent: valaciclovir, qty 1000 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; povidone; magnesium stearate; colloidal anhydrous silica; carnauba wax; colour - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. for the treatment of ophthalmic zoster. for the treatment of recurrent herpes labialis (cold sores) for the treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes. reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with valtrex, it is recommended that patients use safer sex practices. (see precautions). prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - valaciclovir hydrochloride -

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - valaciclovir hydrochloride, quantity: 556 mg (equivalent: valaciclovir, qty 500 mg) - tablet, film coated - excipient ingredients: povidone; crospovidone; colloidal anhydrous silica; carnauba wax; magnesium stearate; microcrystalline cellulose; colour - for the treatment of herpes zoster (shingles) in adult patients who commence therapy within 72 hours of the onset of rash. for the treatment of ophthalmic zoster. for the treatment of recurrent herpes labialis (cold sores) for the treatment of clinical episodes of genital herpes simplex infections. for the prevention of recurrent genital herpes. reduction of transmission of genital herpes in patients suffering from recurrent genital herpes. in addition to therapy with valtrex, it is recommended that patients use safer sex practices. (see precautions). prophylaxis of cytomegalovirus (cmv) infection and disease following solid organ transplantation in patients at risk of cmv disease.

Belġju - Ingliż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - valaciclovir hydrochloride 305,85 mg - eq. valaciclovir 250 mg - film-coated tablet - 250 mg - valaciclovir hydrochloride 305.85 mg - valaciclovir

Belġju - Ingliż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - valaciclovir hydrochloride 1223,4 mg - eq. valaciclovir 1000 mg - film-coated tablet - 1000 mg - valaciclovir hydrochloride 1223.4 mg - valaciclovir

Belġju - Ingliż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - valaciclovir hydrochloride 611,7 mg - eq. valaciclovir 500 mg - film-coated tablet - 500 mg - valaciclovir hydrochloride 611.7 mg - valaciclovir

Belġju - Ingliż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - valaciclovir hydrochloride 556,28 mg - eq. valaciclovir 500 mg - film-coated tablet - 500 mg - valaciclovir hydrochloride 556.28 mg - valaciclovir

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - valaciclovir hydrochloride -